120 related articles for article (PubMed ID: 19689630)
21. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
[TBL] [Abstract][Full Text] [Related]
22. Medication-taking behaviours in young adults with schizophrenia: a pilot study.
Lee H; Kane I; Sereika SM; Cho RY; Jolley CJ
J Psychiatr Ment Health Nurs; 2011 Jun; 18(5):418-24. PubMed ID: 21539687
[TBL] [Abstract][Full Text] [Related]
23. Relational agents as an adjunct in schizophrenia treatment.
Puskar K; Schlenk EA; Callan J; Bickmore T; Sereika S
J Psychosoc Nurs Ment Health Serv; 2011 Aug; 49(8):22-9. PubMed ID: 21766736
[TBL] [Abstract][Full Text] [Related]
24. Course of adherence to medication and quality of life in people with schizophrenia.
Puschner B; Angermeyer MC; Leese M; Thornicroft G; Schene A; Kikkert M; Burti L; Tansella M; Becker T
Psychiatry Res; 2009 Feb; 165(3):224-33. PubMed ID: 19155070
[TBL] [Abstract][Full Text] [Related]
25. Medicaid prescription cost containment and schizophrenia: a retrospective examination.
Farley JF
Med Care; 2010 May; 48(5):440-7. PubMed ID: 20351586
[TBL] [Abstract][Full Text] [Related]
26. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
Bobes J; Fillat O; Arango C
Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
[TBL] [Abstract][Full Text] [Related]
27. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
[TBL] [Abstract][Full Text] [Related]
28. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication.
Gray R; Rofail D; Allen J; Newey T
J Adv Nurs; 2005 Oct; 52(1):31-7. PubMed ID: 16149978
[TBL] [Abstract][Full Text] [Related]
29. Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians.
Hodge K; Jespersen S
Int J Ment Health Nurs; 2008 Feb; 17(1):2-8. PubMed ID: 18211398
[TBL] [Abstract][Full Text] [Related]
30. Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome.
Shi L; Zhao Y; Fonseca V; Ascher-Svanum H; Chiang YJ; Winstead D
Curr Med Res Opin; 2010 Oct; 26(10):2499-506. PubMed ID: 20828361
[TBL] [Abstract][Full Text] [Related]
31. What community living problems do persons with schizophrenia report during periods of stability?
Beebe LH
Perspect Psychiatr Care; 2010 Jan; 46(1):48-55. PubMed ID: 20051078
[TBL] [Abstract][Full Text] [Related]
32. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
Kim SW; Yoon JS; Choi SK
Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system.
Dassa D; Boyer L; Benoit M; Bourcet S; Raymondet P; Bottai T
Aust N Z J Psychiatry; 2010 Oct; 44(10):921-8. PubMed ID: 20932206
[TBL] [Abstract][Full Text] [Related]
34. Assessment of medication adherence in patients with schizophrenia: the Achilles heel of adherence research.
Kikkert MJ; Barbui C; Koeter MW; David AS; Leese M; Tansella M; Gieler A; Puschner B; Schene AH
J Nerv Ment Dis; 2008 Apr; 196(4):274-81. PubMed ID: 18414121
[TBL] [Abstract][Full Text] [Related]
35. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia.
Novick D; Haro JM; Suarez D; Perez V; Dittmann RW; Haddad PM
Psychiatry Res; 2010 Apr; 176(2-3):109-13. PubMed ID: 20185182
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
37. Assessment of clinician awareness of nonadherence using a new structured rating scale.
Clayton CD; Veach J; Macfadden W; Haskins J; Docherty JP; Lindenmayer JP
J Psychiatr Pract; 2010 May; 16(3):164-9. PubMed ID: 20485104
[TBL] [Abstract][Full Text] [Related]
38. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
39. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
[TBL] [Abstract][Full Text] [Related]
40. Understanding adherence to neuroleptic treatment in schizophreniaí.
Vauth R; Löschmann C; Rüsch N; Corrigan PW
Psychiatry Res; 2004 Apr; 126(1):43-9. PubMed ID: 15081626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
